Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981;19(6):403-8.
doi: 10.1007/BF00548582.

Interaction of desipramine and amitriptyline with adrenergic mechanisms in the human iris in vivo

Interaction of desipramine and amitriptyline with adrenergic mechanisms in the human iris in vivo

E Szabadi et al. Eur J Clin Pharmacol. 1981.

Abstract

Mydriatic responses of the pupil were evoked by locally instilled noradrenaline and methoxamine in eight healthy volunteers. The effects of three single oral doses (25 mg, 50 mg and 100 mg) of amitriptyline and desipramine were compared on the mydriatic responses. Both antidepressants potentiated the mydriasis evoked by noradrenaline; desipramine appeared to be approximately four times more potent than amitriptyline. Both antidepressants antagonised the mydriasis evoked by noradrenaline; desipramine appeared to be approximately four times more potent than amitriptyline. Both antidepressants antagonised the mydriasis evoked by methoxamine, amitriptyline being approximately twice as potent as desipramine. It is suggested that the potentiation of the response to noradrenaline may reflect the blockade of the uptake of noradrenaline into adrenergic nerve terminals, whereas the antagonism of the response to methoxamine may reflect the blockade of postsynaptic alpha-adrenoceptors by the antidepressants. It is argued that the interaction of the antidepressants with adrenergic mechanisms could explain why amitriptyline, a potent anticholinergic agent, causes no significant change in resting pupil diameter, while desipramine, a relatively weaker anticholinergic agent, produces a significant mydriasis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pharmacol Exp Ther. 1971 Oct;179(1):47-55 - PubMed
    1. Am J Ophthalmol. 1969 Aug;68(2):216-23 - PubMed
    1. Br J Clin Pharmacol. 1976 Aug;3(4):666-7 - PubMed
    1. Eur J Clin Pharmacol. 1980 Apr;17(4):233-8 - PubMed
    1. Arch Ophthalmol. 1969 May;81(5):622-7 - PubMed

Publication types

LinkOut - more resources